August 03, 2022
The U.S. Securities and Exchange Commission announced Wednesday that a surgical implant company agreed to pay $2 million to end a suit alleging company executives shipped products early to mask failed sales targets, but the company's former CEO said that evidence at trial will show he committed no wrongdoing.